• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于临床局限性前列腺癌病理分期的肿瘤选择研究进展]

[Development of tumor selection based on pathological stage in clinically localized prostate carcinoma].

作者信息

Noldus J, Graefen M, Hammerer P, Henke R P, Huland H

机构信息

Urologische Universitätsklinik Hamburg-Eppendorf.

出版信息

Urologe A. 1998 Mar;37(2):195-8. doi: 10.1007/s001200050173.

DOI:10.1007/s001200050173
PMID:9563134
Abstract

Four hundred and eighty-eight radical retropubic prostatectomies (RRP) were performed on clinically localized prostate cancer at one institution within 5 years (1992-1996). These were then analyzed regarding the migration of pathological tumor stages towards more localized stages. Within the observation period, the annual rate of RRP increased by 81% from 69 to 125 cases. The authors noted a decline in the occurrence of advanced tumor stages (65.0% to 39.2%) and small cancers (< 0.5 cc: 7.2% to 1.6%) and an increase in pathological T2 tumors (30.4% to 55.2%). The rate of positive surgical margins declined from 34.7% to 12.8% (for all pathological stages). These data confirm trends which were observed in the USA with increasing detection and treatment of localized prostate cancer.

摘要

在5年时间里(1992 - 1996年),一家机构对临床局限性前列腺癌患者进行了488例耻骨后根治性前列腺切除术(RRP)。随后对这些病例进行分析,以研究病理肿瘤分期向更局限阶段的转变情况。在观察期内,RRP的年手术率从69例增加到125例,增幅达81%。作者注意到晚期肿瘤分期的发生率有所下降(从65.0%降至39.2%),小癌症(<0.5立方厘米:从7.2%降至1.6%)的发生率下降,而病理T2期肿瘤的发生率有所上升(从30.4%升至55.2%)。手术切缘阳性率从34.7%降至12.8%(所有病理分期)。这些数据证实了在美国观察到的随着局限性前列腺癌检测和治疗增加的趋势。

相似文献

1
[Development of tumor selection based on pathological stage in clinically localized prostate carcinoma].[基于临床局限性前列腺癌病理分期的肿瘤选择研究进展]
Urologe A. 1998 Mar;37(2):195-8. doi: 10.1007/s001200050173.
2
Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.临床分期为T1c与T2的前列腺腺癌根治性前列腺切除术的病理参数:病理分期降低及移行区肿瘤检出率增加。
J Urol. 2002 Aug;168(2):519-24.
3
Stage migration in clinically localized prostate cancer.临床局限性前列腺癌中的分期迁移
Eur Urol. 2000 Jul;38(1):74-8. doi: 10.1159/000020255.
4
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).不可触及前列腺癌的根治性前列腺切除术:约翰·霍普金斯医院对经尿道切除术发现的肿瘤(T1A和T1B期)及穿刺活检发现的肿瘤(T1C期)的治疗经验。
J Urol. 1994 Nov;152(5 Pt 2):1721-9. doi: 10.1016/s0022-5347(17)32370-4.
5
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.机器人辅助腹腔镜根治性前列腺切除术与开放性耻骨后根治性前列腺切除术中阳性手术切缘的发生率及位置比较。
J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90. doi: 10.1016/j.juro.2007.08.008. Epub 2007 Oct 22.
6
Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute.腹腔镜前列腺癌根治术:蒙苏里研究所1000例术后的肿瘤学评估
J Urol. 2003 Apr;169(4):1261-6. doi: 10.1097/01.ju.0000055141.36916.be.
7
Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen.
J Urol. 1994 Jul;152(1):129-31. doi: 10.1016/s0022-5347(17)32834-3.
8
Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.活检样本中癌症的百分比可预测前列腺切除术后的病理结果。
J Urol. 2002 May;167(5):2032-5; discussion 2036. doi: 10.1016/s0022-5347(05)65077-x.
9
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?接受根治性前列腺切除术的患者的病理特征和预后最近有变化吗?
J Urol. 1997 Jun;157(6):2212-8.
10
Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era.自前列腺特异性抗原(PSA)时代开始以来,接受根治性前列腺切除术的临床局限性前列腺癌患者肿瘤特征的变化。
Wien Klin Wochenschr. 2006 Jun;118(11-12):348-54. doi: 10.1007/s00508-006-0608-z.

引用本文的文献

1
Impact of preoperative antiandrogen medication and nerve-sparing surgery on the outcome of radical prostatectomy.术前抗雄激素药物及保留神经手术对根治性前列腺切除术结果的影响。
Int Urol Nephrol. 2008;40(4):965-70. doi: 10.1007/s11255-008-9372-5. Epub 2008 Apr 10.
2
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World J Urol. 2006 Aug;24(3):273-80. doi: 10.1007/s00345-006-0058-2. Epub 2006 Feb 28.
3
[Advantages of nerve-sparing pelvic surgery. Animal experiments and clinical results].[保留神经的盆腔手术的优势。动物实验与临床结果]
Urologe A. 2004 Feb;43(2):141-49. doi: 10.1007/s00120-003-0523-0.